Tarsus Pharmaceuticals to acquire Alkeus for up to $800M
Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) announced a definitive agreement to acquire Alkeus Pharmaceuticals, Inc., a privately held biotechnology company developing ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)

